...
首页> 外文期刊>Revue roumaine de chimie >BINDING OF NORFLOXACIN, ENOXACIN AND ENROFLOXACIN TO CALF THYMUS DNA
【24h】

BINDING OF NORFLOXACIN, ENOXACIN AND ENROFLOXACIN TO CALF THYMUS DNA

机译:诺氟沙星,依诺沙星和依诺沙星与小胸腺DNA的结合

获取原文
获取原文并翻译 | 示例
           

摘要

A number of drugs exert their influence by interaction with nucleic acids, having as effect the inhibition of replication and transcription. The precise mechanism by which these functions are inhibited is unique to each clinically important agent and may involve inhibition of DNA polymerase activity, topoisomerase II activity, etc. A fundamental step in understanding the molecular mechanism of drugs' action is the characterization of their binding to DNA and/or RNA. Fluoroquinolones are a class of antimicrobial antibiotics that destroy bacteria by inhibiting enzymes DNA gyrase and DNA topoisomerase. They are useful in the treatment of many infections, including urinary tract infections, respiratory infections, sexually transmitted diseases, acute bronchitis and sinusitis. In the present study, the interaction of three fluoroquinolones, norfloxacin, enoxacin and enrofloxacin, with calf thymus DNA has been studied. The study has been done by means of using various techniques such as UV-Vis absorption spectroscopy and viscosity measurements. The viscosity experiments have revealed how these drugs bind to DNA while the spectroscopic experiments have allowed the determination of the binding parameters. The results have been processed in terms of Benesi-Hildebrand, Scott and Scatchard models, assuming that binding of drugs to DNA is in 1:1 system and they also have been fitted through the linear or nonlinear regression, assuming that there is one single class of non-interacting binding sites that do not exhibit cooperative behaviour.
机译:许多药物通过与核酸相互作用来发挥作用,从而有效地抑制了复制和转录。抑制这些功能的确切机制是每种临床上重要的药物所独有的,并且可能涉及抑制DNA聚合酶活性,拓扑异构酶II活性等。了解药物作用的分子机制的基本步骤是表征其与药物的结合DNA和/或RNA。氟喹诺酮类药物是一类通过抑制DNA促旋酶和DNA拓扑异构酶破坏细菌的抗菌素。它们可用于治疗许多感染,包括泌尿道感染,呼吸道感染,性传播疾病,急性支气管炎和鼻窦炎。在本研究中,已经研究了三种氟喹诺酮类,诺氟沙星,依诺沙星和恩诺沙星与小牛胸腺DNA的相互作用。该研究是通过使用各种技术完成的,例如紫外可见吸收光谱和粘度测量。粘度实验揭示了这些药物如何与DNA结合,而光谱实验已确定了结合参数。根据Benesi-Hildebrand,Scott和Scatchard模型对结果进行了处理,假设药物与DNA的结合为1:1系统,并且还通过线性或非线性回归进行了拟合,并假设存在一个单一类别不表现出协同行为的非相互作用结合位点。

著录项

  • 来源
    《Revue roumaine de chimie》 |2012年第10期|823-827|共5页
  • 作者单位

    Department of Physical Chemistry, Faculty of Science, University of Pitesti, No 1, Targu din Vale, Pitesti, 110040, Roumania;

    Department of Physical Chemistry, Faculty of Science, University of Pitesti, No 1, Targu din Vale, Pitesti, 110040, Roumania;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号